Vanguard Group
BLFS icon

Vanguard Group’s BioLife Solutions BLFS Stock Holding History

Vanguard Group’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$74.7M Buy
3,087,386
+119,868
+4% +$3.14M ﹤0.01% 1981
2025
Q3 		$75.7M Buy
2,967,518
+70,248
+2% +$1.67M ﹤0.01% 1973
2025
Q2 		$62.4M Buy
2,897,270
+93,130
+3% +$2.1M ﹤0.01% 2033
2025
Q1 		$64M Sell
2,804,140
-32,117
-1% -$846K ﹤0.01% 1989
2024
Q4 		$73.6M Sell
2,836,257
-12,069
-0.4% -$300K ﹤0.01% 1992
2024
Q3 		$71.3M Buy
2,848,326
+61,862
+2% +$1.46M ﹤0.01% 2033
2024
Q2 		$59.7M Sell
2,786,464
-81,871
-3% -$1.59M ﹤0.01% 2075
2024
Q1 		$53.2M Buy
2,868,335
+296,727
+12% +$5.19M ﹤0.01% 2145
2023
Q4 		$41.8M Buy
2,571,608
+30,763
+1% +$392K ﹤0.01% 2256
2023
Q3 		$35.1M Sell
2,540,845
-21,168
-0.8% -$334K ﹤0.01% 2297
2023
Q2 		$56.6M Buy
2,562,013
+71,667
+3% +$1.51M ﹤0.01% 2130
2023
Q1 		$54.2M Buy
2,490,346
+23,415
+0.9% +$527K ﹤0.01% 2139
2022
Q4 		$44.9M Buy
2,466,931
+51,420
+2% +$1.06M ﹤0.01% 2237
2022
Q3 		$55M Buy
2,415,511
+311,913
+15% +$6.67M ﹤0.01% 2134
2022
Q2 		$29.1M Sell
2,103,598
-98,004
-4% -$1.44M ﹤0.01% 2460
2022
Q1 		$50M Buy
2,201,602
+54,344
+3% +$1.43M ﹤0.01% 2304
2021
Q4 		$80M Buy
2,147,258
+62,456
+3% +$2.68M ﹤0.01% 2101
2021
Q3 		$88.2M Buy
2,084,802
+334,308
+19% +$16.1M ﹤0.01% 2048
2021
Q2 		$77.9M Buy
1,750,494
+344,463
+24% +$12.1M ﹤0.01% 2129
2021
Q1 		$50.6M Buy
1,406,031
+126,777
+10% +$5.01M ﹤0.01% 2308
2020
Q4 		$51M Buy
1,279,254
+108,851
+9% +$3.71M ﹤0.01% 2193
2020
Q3 		$33.9M Buy
1,170,403
+388,202
+50% +$8.38M ﹤0.01% 2215
2020
Q2 		$12.8M Sell
782,201
-51,189
-6% -$706K ﹤0.01% 2645
2020
Q1 		$7.92M Buy
833,390
+206,916
+33% +$2.84M ﹤0.01% 2721
2019
Q4 		$10.1M Buy
626,474
+1,992
+0.3% +$32.4K ﹤0.01% 2852
2019
Q3 		$10.4M Sell
624,482
-2,701
-0.4% -$50.7K ﹤0.01% 2799
2019
Q2 		$10.6M Buy
627,183
+12,416
+2% +$216K ﹤0.01% 2825
2019
Q1 		$11M Buy
614,767
+57,499
+10% +$915K ﹤0.01% 2770
2018
Q4 		$6.7M Buy
557,268
+109,284
+24% +$1.31M ﹤0.01% 2952
2018
Q3 		$7.84M Buy
447,984
+134,869
+43% +$2.67M ﹤0.01% 3041
2018
Q2 		$3.57M Buy
313,115
+49,400
+19% +$450K ﹤0.01% 3322
2018
Q1 		$1.35M Buy
263,715
+11,880
+5% +$64.3K ﹤0.01% 3573
2017
Q4 		$1.51M Buy
251,835
+77,102
+44% +$444K ﹤0.01% 3505
2017
Q3 		$1M Buy
174,733
+77,906
+80% +$323K ﹤0.01% 3591
2017
Q2 		$232K Hold
96,827
– – ﹤0.01% 3876
2017
Q1 		$202K Buy
96,827
+1,700
+2% +$3.29K ﹤0.01% 3904
2016
Q4 		$155K Hold
95,127
– – ﹤0.01% 3926
2016
Q3 		$175K Buy
95,127
+25,557
+37% +$48.5K ﹤0.01% 3921
2016
Q2 		$111K Hold
69,570
– – ﹤0.01% 4015
2016
Q1 		$128K Buy
69,570
+1,215
+2% +$2.23K ﹤0.01% 4007
2015
Q4 		$149K Hold
68,355
– – ﹤0.01% 4043
2015
Q3 		$145K Buy
68,355
+41,730
+157% +$90.9K ﹤0.01% 4060
2015
Q2 		$52K Buy
26,625
+15,639
+142% +$31.3K ﹤0.01% 4153
2015
Q1 		$18K Buy
+10,986
New +$20.5K ﹤0.01% 4144

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group's BLFS Position: Q4 2025 in Review

Vanguard Group increased its BioLife Solutions (BLFS) stake by 4% in Q4 2025, buying an estimated $3.14M and bringing the position to 3,087,386 shares worth $74.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1981.

Vanguard Group first reported a position in BLFS in Q1 2015 and has held it in 44 quarters since. The position peaked at $88.2M in Q3 2021. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

  • Vanguard Group held 3,087,386 shares of BioLife Solutions worth $74.7M as of Q4 2025.
  • Vanguard Group bought 119,868 BioLife Solutions shares in Q4 2025, an estimated $3.14M.
  • BioLife Solutions made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1981 holding.
  • Vanguard Group first reported a position in BioLife Solutions in Q1 2015 and has held it in 44 quarters since.
  • Vanguard Group's BioLife Solutions position peaked at $88.2M in Q3 2021.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.